Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01716975
Recruitment Status : Completed
First Posted : October 30, 2012
Last Update Posted : May 3, 2016
Sponsor:
Collaborators:
Syneos Health
NeuroCog Trials, Inc.
Information provided by (Responsible Party):
FORUM Pharmaceuticals Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2016
Actual Study Completion Date : February 2016